Bioethics, health technology reassessment, and management.

Autor: Soril LJ; Department of Community Health Sciences, Cumming School of Medicine, Teaching, Research, and Wellness Building, University of Calgary, Alberta, Canada.; Health Technology Assessment Unit, O'Brien Institute for Public Health, Teaching, Research, and Wellness Building, University of Calgary, Alberta, Canada., Clement FM; Department of Community Health Sciences, Cumming School of Medicine, Teaching, Research, and Wellness Building, University of Calgary, Alberta, Canada.; Health Technology Assessment Unit, O'Brien Institute for Public Health, Teaching, Research, and Wellness Building, University of Calgary, Alberta, Canada., Noseworthy TW; Department of Community Health Sciences, Cumming School of Medicine, Teaching, Research, and Wellness Building, University of Calgary, Alberta, Canada. tnosewor@ucalgary.ca.; Health Technology Assessment Unit, O'Brien Institute for Public Health, Teaching, Research, and Wellness Building, University of Calgary, Alberta, Canada.
Jazyk: angličtina
Zdroj: Healthcare management forum [Healthc Manage Forum] 2016 Nov; Vol. 29 (6), pp. 275-278. Date of Electronic Publication: 2016 Oct 15.
DOI: 10.1177/0840470416659385
Abstrakt: Health Technology Reassessment (HTR) is an emerging area of health services and policy research that supports optimal management of technologies throughout their lifecycle. As a structured, evidence-based assessment of the clinical, economic, social, and ethical impacts of existing technologies, HTR is a means of achieving optimal use, managed exit, and better value for money from technologies used in healthcare. This has been documented as raising ethical concerns among clinicians who are providing direct patient care, particularly when managed exit may be the goal. This article discusses the ethical considerations relevant to clinicians and HTR, using a principles' approach to bioethical decision-making.
(© 2016 The Canadian College of Health Leaders.)
Databáze: MEDLINE